We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Jazz Pharmaceuticals Announces $7.2 Billion Purchase of GW Pharmaceuticals
Jazz Pharmaceuticals Announces $7.2 Billion Purchase of GW Pharmaceuticals
Jazz Pharmaceuticals is set to acquire GW Pharmaceuticals, a UK drugmaker known for its CBD products Epidiolex (cannabidiol) and Sativex (nabiximols), for a whopping $7.2 billion.